Registration Dossier

Diss Factsheets

Administrative data

Description of key information

Candesartan is suspected to cause maldevelopment in fetuses and neonates born to mothers treated with the substance during pregnancy. 
The target organs are bons (ossification abnormalities) and kidney (renal failure).
Angiotensin II receptor antagonists should not be used beyond the first trimester of pregnancy.

Additional information